Clinical Trials Directory

Trials / Unknown

UnknownNCT06358131

Propofol Versus Midazolam in Sedation for Upper and Lower Gastrointestinal Endoscopy.

Status
Unknown
Phase
Phase 1
Study type
Interventional
Enrollment
656 (estimated)
Sponsor
Mansoura University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

There has been rapid growth in the number and complexity of gastrointestinal (GI) endoscopic procedures performed during the last decade. To ensure safe and effective upper GI endoscopy, the choice of an appropriate sedative agent is crucial. Sedation usually categorized into four stages: minimal, moderate, deep and general anesthesia. The upper gastrointestinal \[GI\] endoscopy usually performed under moderate sedation Sedation usually categorized into four stages: minimal, moderate, deep and general anesthesia. The upper gastrointestinal \[GI\] endoscopy usually performed under moderate sedation. Benzodiazepines still the most common sedative agents used for conscious sedation, either solely or in combination with opioids for upper GI endoscopy. Propofol is a hypnotic drug used for induction of anesthesia with short half-life that permits rapid patient recovery and discharge. Thus, its use is for upper GI endoscopy was adopted in many endoscopy centers. So we are going to Evaluate all adverse events related to anesthesia; in patients recruited for upper and lower endoscopy and compare between propofol and midazolam based anesthesia associated adverse events.Also we are going to Evaluate patient and endoscopist satisfaction as regarding propofol and midazolam anesthesia.

Conditions

Interventions

TypeNameDescription
DEVICEEndoscopyupper and lower endoscopy

Timeline

Start date
2022-01-01
Primary completion
2024-08-01
Completion
2024-08-01
First posted
2024-04-10
Last updated
2024-04-10

Locations

2 sites across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06358131. Inclusion in this directory is not an endorsement.